Novel motif:162: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif162_AGTTACCGTCA
|novel_motifs_human_sample_pval=11376-118A8_11051;0.557025,11327-117E4_11969;0.414281,11473-119C6_11054;0.51349,11474-119C7_12067;0....") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:25, 9 September 2013
name: | motif162_AGTTACCGTCA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0046032 | ADP catabolic process | 7.070157e-13 |
GO:0046709 | IDP catabolic process | 7.070157e-13 |
GO:0045214 | sarcomere organization | 1.404690e-11 |
GO:0043623 | cellular protein complex assembly | 8.274964e-11 |
GO:0060415 | muscle tissue morphogenesis | 2.548972e-10 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.992114e-10 |
GO:0048769 | sarcomerogenesis | 3.853452e-10 |
GO:0015942 | formate metabolic process | 4.062762e-10 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.034238e-9 |
GO:0002684 | positive regulation of immune system process | 1.270045e-9 |
GO:0006941 | striated muscle contraction | 3.227687e-9 |
GO:0048739 | cardiac muscle fiber development | 3.937335e-9 |
GO:0072594 | establishment of protein localization to organelle | 3.987017e-9 |
GO:0048644 | muscle organ morphogenesis | 5.224720e-9 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 7.754340e-9 |
GO:0009396 | folic acid-containing compound biosynthetic process | 8.397293e-9 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.291323e-8 |
GO:0032467 | positive regulation of cytokinesis | 1.532394e-8 |
GO:0048205 | COPI coating of Golgi vesicle | 1.944970e-8 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.288180e-8 |
GO:0003278 | apoptosis involved in heart morphogenesis | 2.573269e-8 |
GO:0010288 | response to lead ion | 2.922320e-8 |
GO:0022600 | digestive system process | 3.080184e-8 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 4.525886e-8 |
GO:0048194 | Golgi vesicle budding | 5.205280e-8 |
GO:0043032 | positive regulation of macrophage activation | 5.654194e-8 |
GO:0006955 | immune response | 6.575948e-8 |
GO:0010038 | response to metal ion | 6.657861e-8 |
GO:0034622 | cellular macromolecular complex assembly | 1.072969e-7 |
GO:0007076 | mitotic chromosome condensation | 1.374698e-7 |
GO:0030239 | myofibril assembly | 1.920382e-7 |
GO:0030240 | skeletal muscle thin filament assembly | 1.931611e-7 |
GO:0033690 | positive regulation of osteoblast proliferation | 2.319838e-7 |
GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I | 2.334602e-7 |
GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent | 2.334602e-7 |
GO:0002481 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 2.334602e-7 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 2.334602e-7 |
GO:0051592 | response to calcium ion | 2.388413e-7 |
GO:0010927 | cellular component assembly involved in morphogenesis | 2.458361e-7 |
GO:2000505 | regulation of energy homeostasis | 2.862343e-7 |
GO:0022617 | extracellular matrix disassembly | 3.076501e-7 |
GO:0016558 | protein import into peroxisome matrix | 3.233605e-7 |
GO:0071800 | podosome assembly | 4.126065e-7 |
GO:0010759 | positive regulation of macrophage chemotaxis | 4.434998e-7 |
GO:0051649 | establishment of localization in cell | 4.599177e-7 |
GO:0031032 | actomyosin structure organization | 4.730288e-7 |
GO:0016064 | immunoglobulin mediated immune response | 4.961474e-7 |
GO:0071622 | regulation of granulocyte chemotaxis | 6.077843e-7 |
GO:0006457 | protein folding | 6.154242e-7 |
GO:0002576 | platelet degranulation | 6.418699e-7 |
GO:0010758 | regulation of macrophage chemotaxis | 7.194218e-7 |
GO:0009082 | branched chain family amino acid biosynthetic process | 7.280933e-7 |
GO:0006887 | exocytosis | 8.235726e-7 |
GO:0060164 | regulation of timing of neuron differentiation | 9.935507e-7 |
GO:0050892 | intestinal absorption | 1.035334e-6 |
GO:0002252 | immune effector process | 1.257163e-6 |
GO:0044267 | cellular protein metabolic process | 1.280095e-6 |
GO:0007586 | digestion | 1.319942e-6 |
GO:0043030 | regulation of macrophage activation | 1.353805e-6 |
GO:0006958 | complement activation, classical pathway | 1.353805e-6 |
GO:0032727 | positive regulation of interferon-alpha production | 1.601432e-6 |
GO:0071675 | regulation of mononuclear cell migration | 1.615039e-6 |
GO:0019724 | B cell mediated immunity | 1.900421e-6 |
GO:0006680 | glucosylceramide catabolic process | 1.924215e-6 |
GO:0070489 | T cell aggregation | 1.924215e-6 |
GO:0010623 | developmental programmed cell death | 1.935020e-6 |
GO:0002041 | intussusceptive angiogenesis | 1.967516e-6 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 2.204755e-6 |
GO:0055003 | cardiac myofibril assembly | 2.491755e-6 |
GO:2000304 | positive regulation of ceramide biosynthetic process | 2.768431e-6 |
GO:0002676 | regulation of chronic inflammatory response | 2.894872e-6 |
GO:0048747 | muscle fiber development | 3.340472e-6 |
GO:0010745 | negative regulation of macrophage derived foam cell differentiation | 3.615941e-6 |
GO:0048619 | embryonic hindgut morphogenesis | 3.849084e-6 |
GO:2000741 | positive regulation of mesenchymal stem cell differentiation | 4.027422e-6 |
GO:0006323 | DNA packaging | 4.084862e-6 |
GO:0007442 | hindgut morphogenesis | 4.568929e-6 |
GO:0032655 | regulation of interleukin-12 production | 4.881270e-6 |
GO:0023021 | termination of signal transduction | 5.030571e-6 |
GO:0002443 | leukocyte mediated immunity | 5.032504e-6 |
GO:2000303 | regulation of ceramide biosynthetic process | 5.859961e-6 |
GO:0019538 | protein metabolic process | 6.208263e-6 |
GO:0009083 | branched chain family amino acid catabolic process | 6.337626e-6 |
GO:0042559 | pteridine-containing compound biosynthetic process | 6.857917e-6 |
GO:0045321 | leukocyte activation | 7.380918e-6 |
GO:0061036 | positive regulation of cartilage development | 7.490146e-6 |
GO:0034621 | cellular macromolecular complex subunit organization | 7.993139e-6 |
GO:0007624 | ultradian rhythm | 8.565638e-6 |
GO:0046031 | ADP metabolic process | 9.344507e-6 |
GO:0010763 | positive regulation of fibroblast migration | 9.715898e-6 |
GO:2000507 | positive regulation of energy homeostasis | 1.047165e-5 |
GO:2000253 | positive regulation of feeding behavior | 1.047165e-5 |
GO:0032707 | negative regulation of interleukin-23 production | 1.154003e-5 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1.262966e-5 |
GO:0006605 | protein targeting | 1.296204e-5 |
GO:0051641 | cellular localization | 1.304224e-5 |
GO:0030299 | intestinal cholesterol absorption | 1.470888e-5 |
GO:0014866 | skeletal myofibril assembly | 1.555243e-5 |
GO:0003007 | heart morphogenesis | 1.570056e-5 |
GO:0000070 | mitotic sister chromatid segregation | 1.689514e-5 |
GO:0002577 | regulation of antigen processing and presentation | 1.717361e-5 |
GO:0032891 | negative regulation of organic acid transport | 1.753250e-5 |
GO:0002449 | lymphocyte mediated immunity | 1.904067e-5 |
GO:0044282 | small molecule catabolic process | 1.912375e-5 |
GO:0045075 | regulation of interleukin-12 biosynthetic process | 1.930051e-5 |
GO:0003181 | atrioventricular valve morphogenesis | 2.011533e-5 |
GO:0055002 | striated muscle cell development | 2.178354e-5 |
GO:0046967 | cytosol to ER transport | 2.295309e-5 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.324771e-5 |
GO:0002475 | antigen processing and presentation via MHC class Ib | 2.516814e-5 |
GO:0060658 | nipple morphogenesis | 2.920403e-5 |
GO:0006956 | complement activation | 3.053030e-5 |
GO:0002696 | positive regulation of leukocyte activation | 3.150242e-5 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 3.503319e-5 |
GO:0006542 | glutamine biosynthetic process | 3.719281e-5 |
GO:0000819 | sister chromatid segregation | 3.730848e-5 |
GO:0001775 | cell activation | 3.731843e-5 |
GO:0019320 | hexose catabolic process | 3.751331e-5 |
GO:0090161 | Golgi ribbon formation | 3.876864e-5 |
GO:0002682 | regulation of immune system process | 3.909933e-5 |
GO:0046365 | monosaccharide catabolic process | 4.055343e-5 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 4.233131e-5 |
GO:0043652 | engulfment of apoptotic cell | 4.233131e-5 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 4.233131e-5 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 4.233131e-5 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 4.233131e-5 |
GO:0046512 | sphingosine biosynthetic process | 4.322713e-5 |
GO:0060649 | mammary gland bud elongation | 4.383409e-5 |
GO:0060659 | nipple sheath formation | 4.383409e-5 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 4.551642e-5 |
GO:0045760 | positive regulation of action potential | 4.672595e-5 |
GO:2000739 | regulation of mesenchymal stem cell differentiation | 4.710283e-5 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 4.951801e-5 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.069579e-5 |
GO:0019438 | aromatic compound biosynthetic process | 5.182701e-5 |
GO:0030431 | sleep | 5.359329e-5 |
GO:0046514 | ceramide catabolic process | 5.677472e-5 |
GO:0032369 | negative regulation of lipid transport | 5.996433e-5 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 6.141596e-5 |
GO:0006952 | defense response | 6.207531e-5 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 6.467241e-5 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 7.130243e-5 |
GO:0051712 | positive regulation of killing of cells of other organism | 7.519632e-5 |
GO:0072376 | protein activation cascade | 8.094936e-5 |
GO:0070271 | protein complex biogenesis | 8.460722e-5 |
GO:0019371 | cyclooxygenase pathway | 8.582684e-5 |
GO:0050746 | regulation of lipoprotein metabolic process | 9.349473e-5 |
GO:0055078 | sodium ion homeostasis | 9.411482e-5 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 9.543201e-5 |
GO:0035545 | determination of left/right asymmetry in nervous system | 9.762301e-5 |
GO:0030538 | embryonic genitalia morphogenesis | 9.776708e-5 |
GO:0043412 | macromolecule modification | 9.939307e-5 |
GO:0009593 | detection of chemical stimulus | 1.008816e-4 |
GO:0032425 | positive regulation of mismatch repair | 1.009963e-4 |
GO:0051877 | pigment granule aggregation in cell center | 1.028794e-4 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.054751e-4 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.054751e-4 |
GO:0016046 | detection of fungus | 1.054751e-4 |
GO:0016081 | synaptic vesicle docking involved in exocytosis | 1.072345e-4 |
GO:0050867 | positive regulation of cell activation | 1.078978e-4 |
GO:0006461 | protein complex assembly | 1.084483e-4 |
GO:0071403 | cellular response to high density lipoprotein particle stimulus | 1.097605e-4 |
GO:0071448 | cellular response to alkyl hydroperoxide | 1.097605e-4 |
GO:0031269 | pseudopodium assembly | 1.097605e-4 |
GO:0071315 | cellular response to morphine | 1.097605e-4 |
GO:0071307 | cellular response to vitamin K | 1.097605e-4 |
GO:0050904 | diapedesis | 1.097605e-4 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 1.098702e-4 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.119034e-4 |
GO:0006464 | protein modification process | 1.134580e-4 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.154457e-4 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.183923e-4 |
GO:0006883 | cellular sodium ion homeostasis | 1.189593e-4 |
GO:0009081 | branched chain family amino acid metabolic process | 1.207814e-4 |
GO:0051258 | protein polymerization | 1.218851e-4 |
GO:0006954 | inflammatory response | 1.239693e-4 |
GO:0032465 | regulation of cytokinesis | 1.259968e-4 |
GO:0071103 | DNA conformation change | 1.274955e-4 |
GO:0010951 | negative regulation of endopeptidase activity | 1.301907e-4 |
GO:0006821 | chloride transport | 1.306685e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 1.307780e-4 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 1.318366e-4 |
GO:0045807 | positive regulation of endocytosis | 1.355723e-4 |
GO:0048245 | eosinophil chemotaxis | 1.359785e-4 |
GO:0060027 | convergent extension involved in gastrulation | 1.376319e-4 |
GO:0034613 | cellular protein localization | 1.411123e-4 |
GO:0007522 | visceral muscle development | 1.420798e-4 |
GO:0030048 | actin filament-based movement | 1.442886e-4 |
GO:0050776 | regulation of immune response | 1.470471e-4 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 1.525370e-4 |
GO:0046907 | intracellular transport | 1.572416e-4 |
GO:0006886 | intracellular protein transport | 1.576772e-4 |
GO:0065003 | macromolecular complex assembly | 1.578043e-4 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.579204e-4 |
GO:0046968 | peptide antigen transport | 1.579204e-4 |
GO:0002281 | macrophage activation involved in immune response | 1.644616e-4 |
GO:0051606 | detection of stimulus | 1.727493e-4 |
GO:0051131 | chaperone-mediated protein complex assembly | 1.775096e-4 |
GO:0035234 | germ cell programmed cell death | 1.812229e-4 |
GO:0070727 | cellular macromolecule localization | 1.882339e-4 |
GO:0008634 | negative regulation of survival gene product expression | 1.904810e-4 |
GO:0046683 | response to organophosphorus | 1.929987e-4 |
GO:0033688 | regulation of osteoblast proliferation | 1.935658e-4 |
GO:0002251 | organ or tissue specific immune response | 1.944654e-4 |
GO:0002551 | mast cell chemotaxis | 2.003690e-4 |
GO:0046521 | sphingoid catabolic process | 2.042707e-4 |
GO:0045047 | protein targeting to ER | 2.070897e-4 |
GO:0006626 | protein targeting to mitochondrion | 2.076962e-4 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 2.106110e-4 |
GO:0000117 | regulation of transcription involved in G2/M-phase of mitotic cell cycle | 2.152090e-4 |
GO:0030261 | chromosome condensation | 2.155413e-4 |
GO:0046653 | tetrahydrofolate metabolic process | 2.204255e-4 |
GO:0002426 | immunoglobulin production in mucosal tissue | 2.209987e-4 |
GO:0044356 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine | 2.278918e-4 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 2.335318e-4 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 2.453650e-4 |
GO:0002376 | immune system process | 2.459047e-4 |
GO:0002706 | regulation of lymphocyte mediated immunity | 2.464682e-4 |
GO:0072358 | cardiovascular system development | 2.647060e-4 |
GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 2.712389e-4 |
GO:0015805 | S-adenosylmethionine transport | 2.753261e-4 |
GO:0055001 | muscle cell development | 2.777660e-4 |
GO:0002819 | regulation of adaptive immune response | 2.794644e-4 |
GO:0048280 | vesicle fusion with Golgi apparatus | 2.804275e-4 |
GO:0071477 | cellular hypotonic salinity response | 2.871338e-4 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 2.871338e-4 |
GO:0035635 | entry of bacterium into host cell | 2.871338e-4 |
GO:0051919 | positive regulation of fibrinolysis | 2.871338e-4 |
GO:0030049 | muscle filament sliding | 2.935119e-4 |
GO:0010666 | positive regulation of cardiac muscle cell apoptosis | 2.952244e-4 |
GO:0051650 | establishment of vesicle localization | 2.995556e-4 |
GO:0032695 | negative regulation of interleukin-12 production | 3.027463e-4 |
GO:0061035 | regulation of cartilage development | 3.069799e-4 |
GO:0003209 | cardiac atrium morphogenesis | 3.091669e-4 |
GO:0048259 | regulation of receptor-mediated endocytosis | 3.146540e-4 |
GO:0006625 | protein targeting to peroxisome | 3.173473e-4 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 3.433054e-4 |
GO:0060716 | labyrinthine layer blood vessel development | 3.486706e-4 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 3.521478e-4 |
GO:0031508 | centromeric heterochromatin formation | 3.578092e-4 |
GO:0046500 | S-adenosylmethionine metabolic process | 3.578103e-4 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 3.595538e-4 |
GO:0051246 | regulation of protein metabolic process | 3.638247e-4 |
GO:0044258 | intestinal lipid catabolic process | 3.680073e-4 |
GO:0018350 | protein esterification | 3.680073e-4 |
GO:0006259 | DNA metabolic process | 3.688222e-4 |
GO:0017085 | response to insecticide | 3.742232e-4 |
GO:0030277 | maintenance of gastrointestinal epithelium | 3.828743e-4 |
GO:0002385 | mucosal immune response | 3.848177e-4 |
GO:0048791 | calcium ion-dependent exocytosis of neurotransmitter | 3.916238e-4 |
GO:0035459 | cargo loading into vesicle | 3.978028e-4 |
GO:0072393 | microtubule anchoring at microtubule organizing center | 3.989344e-4 |
GO:0060648 | mammary gland bud morphogenesis | 3.989344e-4 |
GO:0034112 | positive regulation of homotypic cell-cell adhesion | 3.993615e-4 |
GO:0010888 | negative regulation of lipid storage | 4.054296e-4 |
GO:0006007 | glucose catabolic process | 4.176697e-4 |
GO:0071593 | lymphocyte aggregation | 4.241921e-4 |
GO:2001054 | negative regulation of mesenchymal cell apoptosis | 4.413876e-4 |
GO:0055013 | cardiac muscle cell development | 4.420916e-4 |
GO:0009236 | cobalamin biosynthetic process | 4.581684e-4 |
GO:0070252 | actin-mediated cell contraction | 4.613592e-4 |
GO:0031268 | pseudopodium organization | 4.737721e-4 |
GO:0050778 | positive regulation of immune response | 4.776286e-4 |
GO:0006911 | phagocytosis, engulfment | 4.793005e-4 |
GO:0051917 | regulation of fibrinolysis | 4.806538e-4 |
GO:0090307 | spindle assembly involved in mitosis | 5.010762e-4 |
GO:0043574 | peroxisomal transport | 5.029681e-4 |
GO:0072593 | reactive oxygen species metabolic process | 5.330613e-4 |
GO:0071569 | protein ufmylation | 5.514531e-4 |
GO:0006760 | folic acid-containing compound metabolic process | 5.645039e-4 |
GO:0000082 | G1/S transition of mitotic cell cycle | 5.650817e-4 |
GO:0045727 | positive regulation of translation | 5.723597e-4 |
GO:0032940 | secretion by cell | 5.726132e-4 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 5.857362e-4 |
GO:0006546 | glycine catabolic process | 5.967099e-4 |
GO:0046164 | alcohol catabolic process | 6.425074e-4 |
GO:0021544 | subpallium development | 6.436798e-4 |
GO:0032332 | positive regulation of chondrocyte differentiation | 6.462530e-4 |
GO:0002699 | positive regulation of immune effector process | 6.489547e-4 |
GO:0048505 | regulation of timing of cell differentiation | 6.514843e-4 |
GO:0072678 | T cell migration | 6.599043e-4 |
GO:0006953 | acute-phase response | 6.744164e-4 |
GO:0043405 | regulation of MAP kinase activity | 6.927605e-4 |
GO:0060674 | placenta blood vessel development | 6.947703e-4 |
GO:0002366 | leukocyte activation involved in immune response | 7.017620e-4 |
GO:0002694 | regulation of leukocyte activation | 7.162726e-4 |
GO:0060632 | regulation of microtubule-based movement | 7.285161e-4 |
GO:0000165 | MAPKKK cascade | 7.520815e-4 |
GO:0003230 | cardiac atrium development | 7.608170e-4 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 7.762140e-4 |
GO:0002697 | regulation of immune effector process | 7.764692e-4 |
GO:0051412 | response to corticosterone stimulus | 7.829878e-4 |
GO:0015780 | nucleotide-sugar transport | 8.233932e-4 |
GO:0042035 | regulation of cytokine biosynthetic process | 8.321300e-4 |
GO:0006839 | mitochondrial transport | 8.423944e-4 |
GO:0001525 | angiogenesis | 8.648026e-4 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 8.705829e-4 |
GO:0006909 | phagocytosis | 8.741384e-4 |
GO:0002687 | positive regulation of leukocyte migration | 8.947771e-4 |
GO:0042119 | neutrophil activation | 8.987899e-4 |
GO:0046649 | lymphocyte activation | 9.219624e-4 |
GO:0002537 | nitric oxide production involved in inflammatory response | 9.372122e-4 |
GO:0006412 | translation | 9.627735e-4 |
GO:0055119 | relaxation of cardiac muscle | 9.632999e-4 |
GO:0051895 | negative regulation of focal adhesion assembly | 9.752051e-4 |
GO:0007031 | peroxisome organization | 9.782788e-4 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 9.800291e-4 |
GO:0080134 | regulation of response to stress | 9.821226e-4 |
GO:0002377 | immunoglobulin production | 9.851242e-4 |
GO:0051709 | regulation of killing of cells of other organism | 9.887986e-4 |
GO:0046395 | carboxylic acid catabolic process | 9.903750e-4 |
GO:0071353 | cellular response to interleukin-4 | 1.004461e-3 |
GO:0046902 | regulation of mitochondrial membrane permeability | 1.004879e-3 |
GO:0017038 | protein import | 1.018926e-3 |
GO:0035518 | histone H2A monoubiquitination | 1.029577e-3 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.043545e-3 |
GO:0010466 | negative regulation of peptidase activity | 1.049087e-3 |
GO:0010661 | positive regulation of muscle cell apoptosis | 1.049248e-3 |
GO:0002200 | somatic diversification of immune receptors | 1.054524e-3 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.066142e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.093684e-3 |
GO:0032026 | response to magnesium ion | 1.111947e-3 |
GO:0032330 | regulation of chondrocyte differentiation | 1.141134e-3 |
GO:0070383 | DNA cytosine deamination | 1.145372e-3 |
GO:0070668 | positive regulation of mast cell proliferation | 1.167072e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 1.170627e-3 |
GO:0034501 | protein localization to kinetochore | 1.170627e-3 |
GO:0006096 | glycolysis | 1.192653e-3 |
GO:0051648 | vesicle localization | 1.193851e-3 |
GO:0032423 | regulation of mismatch repair | 1.209975e-3 |
GO:0044241 | lipid digestion | 1.239248e-3 |
GO:0002250 | adaptive immune response | 1.240859e-3 |
GO:0060920 | pacemaker cell differentiation | 1.247495e-3 |
GO:0002891 | positive regulation of immunoglobulin mediated immune response | 1.253548e-3 |
GO:0002824 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.265539e-3 |
GO:2000425 | regulation of apoptotic cell clearance | 1.308845e-3 |
GO:0044068 | modulation by symbiont of host cellular process | 1.319937e-3 |
GO:0002253 | activation of immune response | 1.333185e-3 |
GO:0018208 | peptidyl-proline modification | 1.351373e-3 |
GO:0031341 | regulation of cell killing | 1.370069e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 1.386764e-3 |
GO:0006434 | seryl-tRNA aminoacylation | 1.391457e-3 |
GO:0045069 | regulation of viral genome replication | 1.394408e-3 |
GO:0071822 | protein complex subunit organization | 1.410438e-3 |
GO:0007005 | mitochondrion organization | 1.438558e-3 |
GO:0002709 | regulation of T cell mediated immunity | 1.441474e-3 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 1.446256e-3 |
GO:0003136 | negative regulation of heart induction by canonical Wnt receptor signaling pathway | 1.465429e-3 |
GO:0043933 | macromolecular complex subunit organization | 1.468707e-3 |
GO:0008298 | intracellular mRNA localization | 1.483366e-3 |
GO:0032647 | regulation of interferon-alpha production | 1.502078e-3 |
GO:0090197 | positive regulation of chemokine secretion | 1.506378e-3 |
GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation | 1.506378e-3 |
GO:0060259 | regulation of feeding behavior | 1.507437e-3 |
GO:0048845 | venous blood vessel morphogenesis | 1.511857e-3 |
GO:0042450 | arginine biosynthetic process via ornithine | 1.517538e-3 |
GO:0006901 | vesicle coating | 1.530083e-3 |
GO:0002703 | regulation of leukocyte mediated immunity | 1.564291e-3 |
GO:0048285 | organelle fission | 1.568218e-3 |
GO:0051385 | response to mineralocorticoid stimulus | 1.577632e-3 |
GO:0042176 | regulation of protein catabolic process | 1.582680e-3 |
GO:0032890 | regulation of organic acid transport | 1.586043e-3 |
GO:0001816 | cytokine production | 1.588781e-3 |
GO:0008272 | sulfate transport | 1.608182e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 1.615547e-3 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 1.623737e-3 |
GO:0031295 | T cell costimulation | 1.628159e-3 |
GO:0072385 | minus-end-directed organelle transport along microtubule | 1.651772e-3 |
GO:0045061 | thymic T cell selection | 1.659356e-3 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.662620e-3 |
GO:0031349 | positive regulation of defense response | 1.704695e-3 |
GO:0007018 | microtubule-based movement | 1.708231e-3 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.715192e-3 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.735523e-3 |
GO:0006527 | arginine catabolic process | 1.735523e-3 |
GO:0002344 | B cell affinity maturation | 1.743285e-3 |
GO:0045039 | protein import into mitochondrial inner membrane | 1.778821e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 1.778987e-3 |
GO:0019220 | regulation of phosphate metabolic process | 1.786384e-3 |
GO:0006099 | tricarboxylic acid cycle | 1.790380e-3 |
GO:0046483 | heterocycle metabolic process | 1.790430e-3 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.823766e-3 |
GO:0034655 | nucleobase-containing compound catabolic process | 1.839389e-3 |
GO:0033365 | protein localization to organelle | 1.844894e-3 |
GO:0051384 | response to glucocorticoid stimulus | 1.849600e-3 |
GO:0010955 | negative regulation of protein processing | 1.853233e-3 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.905511e-3 |
GO:0030252 | growth hormone secretion | 1.922542e-3 |
GO:0046356 | acetyl-CoA catabolic process | 1.933266e-3 |
GO:0042663 | regulation of endodermal cell fate specification | 1.950159e-3 |
GO:0031343 | positive regulation of cell killing | 1.960300e-3 |
GO:0006084 | acetyl-CoA metabolic process | 1.973787e-3 |
GO:0060572 | morphogenesis of an epithelial bud | 2.016797e-3 |
GO:0070585 | protein localization in mitochondrion | 2.036158e-3 |
GO:0071361 | cellular response to ethanol | 2.046023e-3 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.092945e-3 |
GO:0002889 | regulation of immunoglobulin mediated immune response | 2.098360e-3 |
GO:0051918 | negative regulation of fibrinolysis | 2.111328e-3 |
GO:0045087 | innate immune response | 2.113605e-3 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.152374e-3 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 2.184742e-3 |
GO:0006687 | glycosphingolipid metabolic process | 2.188267e-3 |
GO:0006672 | ceramide metabolic process | 2.207232e-3 |
GO:0035606 | peptidyl-cysteine S-trans-nitrosylation | 2.227027e-3 |
GO:0043064 | flagellum organization | 2.299410e-3 |
GO:0002440 | production of molecular mediator of immune response | 2.324526e-3 |
GO:0060972 | left/right pattern formation | 2.331797e-3 |
GO:0060729 | intestinal epithelial structure maintenance | 2.331797e-3 |
GO:0051256 | spindle midzone assembly involved in mitosis | 2.369838e-3 |
GO:0002712 | regulation of B cell mediated immunity | 2.425806e-3 |
GO:0006730 | one-carbon metabolic process | 2.451695e-3 |
GO:0045006 | DNA deamination | 2.462946e-3 |
GO:0006458 | 'de novo' protein folding | 2.484476e-3 |
GO:0016032 | viral reproduction | 2.495774e-3 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 2.499069e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 2.499069e-3 |
GO:0018149 | peptide cross-linking | 2.522075e-3 |
GO:0003281 | ventricular septum development | 2.564246e-3 |
GO:0002274 | myeloid leukocyte activation | 2.614595e-3 |
GO:0050870 | positive regulation of T cell activation | 2.619105e-3 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 2.621429e-3 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.636005e-3 |
GO:0051881 | regulation of mitochondrial membrane potential | 2.677385e-3 |
GO:0045209 | MAPK phosphatase export from nucleus, leptomycin B sensitive | 2.714445e-3 |
GO:0045204 | MAPK export from nucleus | 2.714445e-3 |
GO:0048520 | positive regulation of behavior | 2.730307e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 2.731607e-3 |
GO:0060009 | Sertoli cell development | 2.734537e-3 |
GO:0031347 | regulation of defense response | 2.766274e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 2.770628e-3 |
GO:0048630 | skeletal muscle tissue growth | 2.773519e-3 |
GO:0007217 | tachykinin receptor signaling pathway | 2.773519e-3 |
GO:0002825 | regulation of T-helper 1 type immune response | 2.808338e-3 |
GO:0034605 | cellular response to heat | 2.835373e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 2.867517e-3 |
GO:0035304 | regulation of protein dephosphorylation | 2.884900e-3 |
GO:0010035 | response to inorganic substance | 2.895412e-3 |
GO:0007507 | heart development | 2.909866e-3 |
GO:0090075 | relaxation of muscle | 2.924041e-3 |
GO:0010766 | negative regulation of sodium ion transport | 2.924041e-3 |
GO:0002831 | regulation of response to biotic stimulus | 2.954111e-3 |
GO:0032715 | negative regulation of interleukin-6 production | 2.973802e-3 |
GO:0072529 | pyrimidine-containing compound catabolic process | 3.035708e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.059990e-3 |
GO:0042116 | macrophage activation | 3.066808e-3 |
GO:0032103 | positive regulation of response to external stimulus | 3.107171e-3 |
GO:0046835 | carbohydrate phosphorylation | 3.113978e-3 |
GO:0015809 | arginine transport | 3.113978e-3 |
GO:0003222 | ventricular trabecular myocardium morphogenesis | 3.132384e-3 |
GO:0007006 | mitochondrial membrane organization | 3.142019e-3 |
GO:0032402 | melanosome transport | 3.219107e-3 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 3.277227e-3 |
GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 3.277227e-3 |
GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 3.277227e-3 |
GO:0048806 | genitalia development | 3.361434e-3 |
GO:0010529 | negative regulation of transposition | 3.364154e-3 |
GO:0043549 | regulation of kinase activity | 3.380737e-3 |
GO:0043666 | regulation of phosphoprotein phosphatase activity | 3.389033e-3 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 3.419984e-3 |
GO:0071476 | cellular hypotonic response | 3.517702e-3 |
GO:0001942 | hair follicle development | 3.523566e-3 |
GO:0060928 | atrioventricular node cell development | 3.581158e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 3.581158e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 3.581158e-3 |
GO:0034120 | positive regulation of erythrocyte aggregation | 3.581158e-3 |
GO:0006437 | tyrosyl-tRNA aminoacylation | 3.581158e-3 |
GO:0003342 | proepicardium development | 3.581158e-3 |
GO:0010757 | negative regulation of plasminogen activation | 3.590264e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 3.595213e-3 |
GO:0009063 | cellular amino acid catabolic process | 3.635363e-3 |
GO:0008652 | cellular amino acid biosynthetic process | 3.650630e-3 |
GO:0032790 | ribosome disassembly | 3.672583e-3 |
GO:0034763 | negative regulation of transmembrane transport | 3.694146e-3 |
GO:0006020 | inositol metabolic process | 3.717496e-3 |
GO:0042633 | hair cycle | 3.891183e-3 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 3.926540e-3 |
GO:0042325 | regulation of phosphorylation | 3.930995e-3 |
GO:0000266 | mitochondrial fission | 3.932334e-3 |
GO:0014823 | response to activity | 3.954765e-3 |
GO:0042297 | vocal learning | 3.979173e-3 |
GO:0071472 | cellular response to salt stress | 3.979173e-3 |
GO:0030070 | insulin processing | 3.979173e-3 |
GO:0006903 | vesicle targeting | 4.003451e-3 |
GO:0009164 | nucleoside catabolic process | 4.027522e-3 |
GO:0045650 | negative regulation of macrophage differentiation | 4.078462e-3 |
GO:0090224 | regulation of spindle organization | 4.155574e-3 |
GO:0006413 | translational initiation | 4.163984e-3 |
GO:0033153 | T cell receptor V(D)J recombination | 4.165160e-3 |
GO:0030187 | melatonin biosynthetic process | 4.276384e-3 |
GO:0001914 | regulation of T cell mediated cytotoxicity | 4.283985e-3 |
GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning | 4.286268e-3 |
GO:0048514 | blood vessel morphogenesis | 4.339538e-3 |
GO:0002339 | B cell selection | 4.406323e-3 |
GO:0002821 | positive regulation of adaptive immune response | 4.455346e-3 |
GO:0032224 | positive regulation of synaptic transmission, cholinergic | 4.483921e-3 |
GO:0043271 | negative regulation of ion transport | 4.518654e-3 |
GO:0072091 | regulation of stem cell proliferation | 4.524300e-3 |
GO:0016048 | detection of temperature stimulus | 4.570057e-3 |
GO:0002826 | negative regulation of T-helper 1 type immune response | 4.570057e-3 |
GO:0045070 | positive regulation of viral genome replication | 4.637683e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 4.859150e-9 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 7.766737e-7 |
GO:0033382 | maintenance of granzyme B location in T cell secretory granule | 8.689332e-7 |
GO:0033373 | maintenance of protease location in mast cell secretory granule | 8.689332e-7 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 1.829995e-6 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 2.045537e-6 |
GO:0055013 | cardiac muscle cell development | 3.523379e-6 |
GO:0010955 | negative regulation of protein processing | 3.594206e-6 |
GO:0018149 | peptide cross-linking | 3.699412e-6 |
GO:0003350 | pulmonary myocardium development | 4.656760e-6 |
GO:0046373 | L-arabinose metabolic process | 4.979264e-6 |
GO:0043366 | beta selection | 6.361060e-6 |
GO:0019054 | modulation by virus of host cellular process | 6.538998e-6 |
GO:0032609 | interferon-gamma production | 6.582643e-6 |
GO:0006507 | GPI anchor release | 8.421886e-6 |
GO:0034097 | response to cytokine stimulus | 8.454378e-6 |
GO:0032645 | regulation of granulocyte macrophage colony-stimulating factor production | 9.726181e-6 |
GO:0048668 | collateral sprouting | 1.019395e-5 |
GO:0090307 | spindle assembly involved in mitosis | 1.019395e-5 |
GO:0055006 | cardiac cell development | 1.157403e-5 |
GO:0031396 | regulation of protein ubiquitination | 1.241526e-5 |
GO:0031397 | negative regulation of protein ubiquitination | 1.276247e-5 |
GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway | 1.677114e-5 |
GO:0043056 | forward locomotion | 2.316209e-5 |
GO:0060658 | nipple morphogenesis | 2.772759e-5 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 3.025955e-5 |
GO:0051788 | response to misfolded protein | 3.132951e-5 |
GO:0071356 | cellular response to tumor necrosis factor | 3.147730e-5 |
GO:0008625 | induction of apoptosis via death domain receptors | 3.510478e-5 |
GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination | 3.551852e-5 |
GO:0033364 | mast cell secretory granule organization | 3.620060e-5 |
GO:0061088 | regulation of sequestering of zinc ion | 3.720061e-5 |
GO:0045916 | negative regulation of complement activation | 3.733906e-5 |
GO:0006116 | NADH oxidation | 3.733906e-5 |
GO:0007099 | centriole replication | 4.286607e-5 |
GO:0034612 | response to tumor necrosis factor | 4.993235e-5 |
GO:0043543 | protein acylation | 5.736255e-5 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 6.148426e-5 |
GO:0070613 | regulation of protein processing | 6.740652e-5 |
GO:0051310 | metaphase plate congression | 7.238794e-5 |
GO:0030204 | chondroitin sulfate metabolic process | 7.526950e-5 |
GO:0033363 | secretory granule organization | 8.112865e-5 |
GO:0031018 | endocrine pancreas development | 8.684494e-5 |
GO:0050869 | negative regulation of B cell activation | 9.078363e-5 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 1.012310e-4 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway | 1.097731e-4 |
GO:0060537 | muscle tissue development | 1.138627e-4 |
GO:0006955 | immune response | 1.190209e-4 |
GO:0001869 | negative regulation of complement activation, lectin pathway | 1.199863e-4 |
GO:0007229 | integrin-mediated signaling pathway | 1.205873e-4 |
GO:0033058 | directional locomotion | 1.315716e-4 |
GO:0002921 | negative regulation of humoral immune response | 1.379364e-4 |
GO:0043137 | DNA replication, removal of RNA primer | 1.393850e-4 |
GO:0018364 | peptidyl-glutamine methylation | 1.393850e-4 |
GO:0046632 | alpha-beta T cell differentiation | 1.487993e-4 |
GO:2000078 | positive regulation of type B pancreatic cell development | 1.594900e-4 |
GO:0035928 | rRNA import into mitochondrion | 1.594900e-4 |
GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 1.649458e-4 |
GO:0051303 | establishment of chromosome localization | 1.701284e-4 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 1.870269e-4 |
GO:0060841 | venous blood vessel development | 1.911426e-4 |
GO:0071345 | cellular response to cytokine stimulus | 1.916395e-4 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 1.937875e-4 |
GO:0014706 | striated muscle tissue development | 1.939703e-4 |
GO:0030856 | regulation of epithelial cell differentiation | 1.978898e-4 |
GO:0010625 | positive regulation of Schwann cell proliferation | 2.022941e-4 |
GO:0043967 | histone H4 acetylation | 2.024094e-4 |
GO:0060427 | lung connective tissue development | 2.086044e-4 |
GO:0006278 | RNA-dependent DNA replication | 2.188977e-4 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 2.359051e-4 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 2.544763e-4 |
GO:0050710 | negative regulation of cytokine secretion | 2.612194e-4 |
GO:0055003 | cardiac myofibril assembly | 2.693192e-4 |
GO:0008624 | induction of apoptosis by extracellular signals | 2.744623e-4 |
GO:0007080 | mitotic metaphase plate congression | 2.793210e-4 |
GO:0006273 | lagging strand elongation | 2.847092e-4 |
GO:0045579 | positive regulation of B cell differentiation | 2.929402e-4 |
GO:0046631 | alpha-beta T cell activation | 3.011267e-4 |
GO:0022007 | convergent extension involved in neural plate elongation | 3.052094e-4 |
GO:0006473 | protein acetylation | 3.251542e-4 |
GO:0045079 | negative regulation of chemokine biosynthetic process | 3.420639e-4 |
GO:0050821 | protein stabilization | 3.891984e-4 |
GO:0007144 | female meiosis I | 3.902791e-4 |
GO:0030449 | regulation of complement activation | 3.987431e-4 |
GO:0072259 | metanephric interstitial cell development | 4.143150e-4 |
GO:0072208 | metanephric smooth muscle tissue development | 4.143150e-4 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 4.143150e-4 |
GO:0072184 | renal vesicle progenitor cell differentiation | 4.143150e-4 |
GO:0072168 | specification of anterior mesonephric tubule identity | 4.143150e-4 |
GO:0072169 | specification of posterior mesonephric tubule identity | 4.143150e-4 |
GO:0002366 | leukocyte activation involved in immune response | 4.428746e-4 |
GO:0060174 | limb bud formation | 4.483807e-4 |
GO:0002281 | macrophage activation involved in immune response | 4.529460e-4 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 4.726416e-4 |
GO:0007130 | synaptonemal complex assembly | 4.752205e-4 |
GO:0007340 | acrosome reaction | 5.179145e-4 |
GO:0071477 | cellular hypotonic salinity response | 5.229084e-4 |
GO:0072141 | renal interstitial cell development | 5.269014e-4 |
GO:0019221 | cytokine-mediated signaling pathway | 5.416633e-4 |
GO:0018193 | peptidyl-amino acid modification | 5.617164e-4 |
GO:0072608 | interleukin-10 secretion | 5.724153e-4 |
GO:0072643 | interferon-gamma secretion | 5.724153e-4 |
GO:0070963 | positive regulation of neutrophil mediated killing of gram-negative bacterium | 5.724153e-4 |
GO:0090198 | negative regulation of chemokine secretion | 5.724153e-4 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 5.724153e-4 |
GO:0035926 | chemokine (C-C motif) ligand 2 secretion | 5.724153e-4 |
GO:0043311 | positive regulation of eosinophil degranulation | 5.724153e-4 |
GO:0007155 | cell adhesion | 6.040736e-4 |
GO:0034501 | protein localization to kinetochore | 6.060630e-4 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 6.079567e-4 |
GO:0035966 | response to topologically incorrect protein | 6.108158e-4 |
GO:0006022 | aminoglycan metabolic process | 6.108158e-4 |
GO:0046641 | positive regulation of alpha-beta T cell proliferation | 6.204037e-4 |
GO:0035372 | protein localization to microtubule | 6.240948e-4 |
GO:0050930 | induction of positive chemotaxis | 6.301357e-4 |
GO:0032462 | regulation of protein homooligomerization | 6.303616e-4 |
GO:0033144 | negative regulation of steroid hormone receptor signaling pathway | 6.567847e-4 |
GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 6.576729e-4 |
GO:0045401 | positive regulation of interleukin-3 biosynthetic process | 6.576729e-4 |
GO:0009750 | response to fructose stimulus | 6.805977e-4 |
GO:0006434 | seryl-tRNA aminoacylation | 6.867327e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 6.968437e-4 |
GO:0070536 | protein K63-linked deubiquitination | 7.025512e-4 |
GO:0003215 | cardiac right ventricle morphogenesis | 7.086570e-4 |
GO:0048840 | otolith development | 7.349789e-4 |
GO:0022407 | regulation of cell-cell adhesion | 7.538304e-4 |
GO:0022610 | biological adhesion | 7.787373e-4 |
GO:0051298 | centrosome duplication | 7.831550e-4 |
GO:0072190 | ureter urothelium development | 7.982572e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 7.982572e-4 |
GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | 8.017976e-4 |
GO:0060373 | regulation of ventricular cardiomyocyte membrane depolarization | 8.017976e-4 |
GO:0034227 | tRNA thio-modification | 8.017976e-4 |
GO:0061364 | apoptosis involved in luteolysis | 8.860910e-4 |
GO:0007040 | lysosome organization | 9.138433e-4 |
GO:0060554 | induction of necroptosis of activated-T cells | 9.167016e-4 |
GO:0042628 | mating plug formation | 1.003175e-3 |
GO:0006915 | apoptosis | 1.019162e-3 |
GO:0042110 | T cell activation | 1.026776e-3 |
GO:0002312 | B cell activation involved in immune response | 1.031230e-3 |
GO:0022408 | negative regulation of cell-cell adhesion | 1.042743e-3 |
GO:0042176 | regulation of protein catabolic process | 1.063954e-3 |
GO:0031016 | pancreas development | 1.077109e-3 |
GO:0045090 | retroviral genome replication | 1.111225e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 1.125499e-3 |
GO:0006302 | double-strand break repair | 1.129004e-3 |
GO:0030502 | negative regulation of bone mineralization | 1.159247e-3 |
GO:0032011 | ARF protein signal transduction | 1.161993e-3 |
GO:0072573 | tolerance induction to lipopolysaccharide | 1.175341e-3 |
GO:2000349 | negative regulation of CD40 signaling pathway | 1.175341e-3 |
GO:0002632 | negative regulation of granuloma formation | 1.175341e-3 |
GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.175341e-3 |
GO:0070429 | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.175341e-3 |
GO:0034148 | negative regulation of toll-like receptor 5 signaling pathway | 1.175341e-3 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 1.179120e-3 |
GO:0009566 | fertilization | 1.202178e-3 |
GO:0022010 | central nervous system myelination | 1.218438e-3 |
GO:0030203 | glycosaminoglycan metabolic process | 1.238425e-3 |
GO:0031400 | negative regulation of protein modification process | 1.254796e-3 |
GO:0072560 | type B pancreatic cell maturation | 1.282963e-3 |
GO:0051142 | positive regulation of NK T cell proliferation | 1.282963e-3 |
GO:0070168 | negative regulation of biomineral tissue development | 1.350125e-3 |
GO:0090005 | negative regulation of establishment of protein localization in plasma membrane | 1.382937e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 1.382937e-3 |
GO:0006709 | progesterone catabolic process | 1.545983e-3 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 1.554899e-3 |
GO:0002507 | tolerance induction | 1.562468e-3 |
GO:0022409 | positive regulation of cell-cell adhesion | 1.650794e-3 |
GO:0034115 | negative regulation of heterotypic cell-cell adhesion | 1.662456e-3 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 1.665855e-3 |
GO:2000347 | positive regulation of hepatocyte proliferation | 1.682314e-3 |
GO:0032713 | negative regulation of interleukin-4 production | 1.708254e-3 |
GO:0018209 | peptidyl-serine modification | 1.728836e-3 |
GO:0006043 | glucosamine catabolic process | 1.740395e-3 |
GO:0071472 | cellular response to salt stress | 1.743234e-3 |
GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity | 1.743234e-3 |
GO:0007052 | mitotic spindle organization | 1.799502e-3 |
GO:0006260 | DNA replication | 1.815078e-3 |
GO:0032692 | negative regulation of interleukin-1 production | 1.822860e-3 |
GO:0005513 | detection of calcium ion | 1.885100e-3 |
GO:0007567 | parturition | 1.885100e-3 |
GO:2000657 | negative regulation of apolipoprotein binding | 1.887677e-3 |
GO:0048047 | mating behavior, sex discrimination | 1.887677e-3 |
GO:0001309 | age-dependent telomere shortening | 1.887677e-3 |
GO:0002124 | territorial aggressive behavior | 1.887677e-3 |
GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway | 1.887677e-3 |
GO:0002098 | tRNA wobble uridine modification | 1.919361e-3 |
GO:0046676 | negative regulation of insulin secretion | 1.986822e-3 |
GO:0016265 | death | 2.011414e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.028686e-3 |
GO:0034383 | low-density lipoprotein particle clearance | 2.057397e-3 |
GO:0031348 | negative regulation of defense response | 2.057581e-3 |
GO:0090076 | relaxation of skeletal muscle | 2.106662e-3 |
GO:0070432 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.106662e-3 |
GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.106662e-3 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 2.106662e-3 |
GO:0045732 | positive regulation of protein catabolic process | 2.109137e-3 |
GO:0012501 | programmed cell death | 2.193574e-3 |
GO:0051817 | modification of morphology or physiology of other organism involved in symbiotic interaction | 2.231103e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 2.234462e-3 |
GO:0000239 | pachytene | 2.286345e-3 |
GO:2000778 | positive regulation of interleukin-6 secretion | 2.299704e-3 |
GO:0007019 | microtubule depolymerization | 2.299704e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 2.348177e-3 |
GO:0033365 | protein localization to organelle | 2.393298e-3 |
GO:0019321 | pentose metabolic process | 2.397070e-3 |
GO:0042574 | retinal metabolic process | 2.456489e-3 |
GO:0030917 | midbrain-hindbrain boundary development | 2.501579e-3 |
GO:0051048 | negative regulation of secretion | 2.519731e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 2.527271e-3 |
GO:0043523 | regulation of neuron apoptosis | 2.543863e-3 |
GO:0022616 | DNA strand elongation | 2.578506e-3 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 2.578506e-3 |
GO:0045321 | leukocyte activation | 2.581929e-3 |
GO:0007098 | centrosome cycle | 2.602011e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 2.610852e-3 |
GO:0014819 | regulation of skeletal muscle contraction | 2.665665e-3 |
GO:0032094 | response to food | 2.710862e-3 |
GO:0018394 | peptidyl-lysine acetylation | 2.783240e-3 |
GO:0007519 | skeletal muscle tissue development | 2.851158e-3 |
GO:0043302 | positive regulation of leukocyte degranulation | 2.853385e-3 |
GO:0032817 | regulation of natural killer cell proliferation | 2.873743e-3 |
GO:0032465 | regulation of cytokinesis | 2.906614e-3 |
GO:2000256 | positive regulation of male germ cell proliferation | 2.931989e-3 |
GO:0042231 | interleukin-13 biosynthetic process | 2.931989e-3 |
GO:0090278 | negative regulation of peptide hormone secretion | 2.937478e-3 |
GO:0019853 | L-ascorbic acid biosynthetic process | 2.952859e-3 |
GO:0008219 | cell death | 2.968935e-3 |
GO:0005997 | xylulose metabolic process | 2.971369e-3 |
GO:0032691 | negative regulation of interleukin-1 beta production | 2.999562e-3 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 3.000228e-3 |
GO:0070193 | synaptonemal complex organization | 3.000228e-3 |
GO:0002285 | lymphocyte activation involved in immune response | 3.023148e-3 |
GO:0071173 | spindle assembly checkpoint | 3.204655e-3 |
GO:2000348 | regulation of CD40 signaling pathway | 3.204655e-3 |
GO:0070936 | protein K48-linked ubiquitination | 3.255563e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 3.278671e-3 |
GO:0050727 | regulation of inflammatory response | 3.375057e-3 |
GO:0060100 | positive regulation of phagocytosis, engulfment | 3.446701e-3 |
GO:0009586 | rhodopsin mediated phototransduction | 3.446701e-3 |
GO:0030879 | mammary gland development | 3.466085e-3 |
GO:0044003 | modification by symbiont of host morphology or physiology | 3.518200e-3 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 3.577478e-3 |
GO:0046649 | lymphocyte activation | 3.596515e-3 |
GO:0001754 | eye photoreceptor cell differentiation | 3.613228e-3 |
GO:0032232 | negative regulation of actin filament bundle assembly | 3.667716e-3 |
GO:0045602 | negative regulation of endothelial cell differentiation | 3.670896e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 3.670896e-3 |
GO:0048389 | intermediate mesoderm development | 3.670896e-3 |
GO:0043402 | glucocorticoid mediated signaling pathway | 3.670896e-3 |
GO:0032425 | positive regulation of mismatch repair | 3.670896e-3 |
GO:0061113 | pancreas morphogenesis | 3.673283e-3 |
GO:0006475 | internal protein amino acid acetylation | 3.737598e-3 |
GO:0042095 | interferon-gamma biosynthetic process | 3.765551e-3 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 3.765551e-3 |
GO:0015889 | cobalamin transport | 3.765551e-3 |
GO:0072012 | glomerulus vasculature development | 3.831357e-3 |
GO:0045824 | negative regulation of innate immune response | 3.831357e-3 |
GO:0033085 | negative regulation of T cell differentiation in thymus | 3.840474e-3 |
GO:0042953 | lipoprotein transport | 3.861818e-3 |
GO:0002315 | marginal zone B cell differentiation | 3.898282e-3 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 3.939741e-3 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 3.939741e-3 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.939741e-3 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 3.939741e-3 |
GO:0042759 | long-chain fatty acid biosynthetic process | 4.175570e-3 |
GO:0048478 | replication fork protection | 4.269684e-3 |
GO:0042851 | L-alanine metabolic process | 4.269684e-3 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 4.285826e-3 |
GO:0071476 | cellular hypotonic response | 4.325944e-3 |
GO:0001554 | luteolysis | 4.325944e-3 |
GO:0031122 | cytoplasmic microtubule organization | 4.381076e-3 |
GO:0003341 | cilium movement | 4.483070e-3 |
GO:0070059 | apoptosis in response to endoplasmic reticulum stress | 4.499691e-3 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.516415e-3 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 4.516415e-3 |
GO:0019464 | glycine decarboxylation via glycine cleavage system | 4.516415e-3 |
GO:0034629 | cellular protein complex localization | 4.569565e-3 |
GO:0042098 | T cell proliferation | 4.629592e-3 |
GO:0097028 | dendritic cell differentiation | 4.692020e-3 |
GO:0000189 | MAPK import into nucleus | 4.692020e-3 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 4.692020e-3 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 4.702322e-3 |
GO:0048846 | axon extension involved in axon guidance | 4.702322e-3 |
GO:0060538 | skeletal muscle organ development | 4.716344e-3 |
GO:0042384 | cilium assembly | 4.728572e-3 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 4.734883e-3 |
GO:0003161 | cardiac conduction system development | 4.738285e-3 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.928230e-3 |
GO:0070542 | response to fatty acid | 5.016745e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 5.060142e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 5.060142e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 5.075088e-3 |
GO:0006528 | asparagine metabolic process | 5.075088e-3 |
GO:0048844 | artery morphogenesis | 5.075911e-3 |
GO:0010749 | regulation of nitric oxide mediated signal transduction | 5.079624e-3 |
GO:0032930 | positive regulation of superoxide anion generation | 5.079624e-3 |
GO:0009791 | post-embryonic development | 5.141303e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 5.338715e-3 |
GO:0006505 | GPI anchor metabolic process | 5.438734e-3 |
GO:0032459 | regulation of protein oligomerization | 5.520578e-3 |
GO:0006029 | proteoglycan metabolic process | 5.620949e-3 |
GO:0031577 | spindle checkpoint | 5.627673e-3 |
GO:0043982 | histone H4-K8 acetylation | 5.732341e-3 |
GO:0043981 | histone H4-K5 acetylation | 5.732341e-3 |
GO:0030500 | regulation of bone mineralization | 5.739616e-3 |
GO:0046530 | photoreceptor cell differentiation | 5.742772e-3 |
GO:0060285 | ciliary cell motility | 5.878349e-3 |
GO:0032347 | regulation of aldosterone biosynthetic process | 5.878349e-3 |
GO:0043309 | regulation of eosinophil degranulation | 5.921986e-3 |
GO:0097029 | mature dendritic cell differentiation | 5.921986e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 6.000148e-3 |
GO:2000543 | positive regulation of gastrulation | 6.139314e-3 |
GO:0007635 | chemosensory behavior | 6.139314e-3 |
GO:0021903 | rostrocaudal neural tube patterning | 6.232556e-3 |
GO:0051276 | chromosome organization | 6.508845e-3 |
GO:0032467 | positive regulation of cytokinesis | 6.543766e-3 |
GO:0007160 | cell-matrix adhesion | 6.554402e-3 |
GO:0030217 | T cell differentiation | 6.588892e-3 |
GO:0035644 | phosphoanandamide dephosphorylation | 6.785340e-3 |
GO:0010757 | negative regulation of plasminogen activation | 6.844614e-3 |
GO:0030858 | positive regulation of epithelial cell differentiation | 6.882808e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 6.965286e-3 |
GO:0009083 | branched chain family amino acid catabolic process | 6.970603e-3 |
GO:0032349 | positive regulation of aldosterone biosynthetic process | 6.978598e-3 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 7.082847e-3 |
GO:0060252 | positive regulation of glial cell proliferation | 7.217987e-3 |
GO:0043652 | engulfment of apoptotic cell | 7.217987e-3 |
GO:0070509 | calcium ion import | 7.250656e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 7.267574e-3 |
GO:0050709 | negative regulation of protein secretion | 7.306872e-3 |
GO:0045087 | innate immune response | 7.328704e-3 |
GO:0030521 | androgen receptor signaling pathway | 7.428382e-3 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 7.485145e-3 |
GO:0050810 | regulation of steroid biosynthetic process | 7.511360e-3 |
GO:0070933 | histone H4 deacetylation | 7.525331e-3 |
GO:0001556 | oocyte maturation | 7.620841e-3 |
GO:0055007 | cardiac muscle cell differentiation | 7.740462e-3 |
GO:0019236 | response to pheromone | 7.906191e-3 |
GO:0045190 | isotype switching | 7.957647e-3 |
GO:0035304 | regulation of protein dephosphorylation | 7.957647e-3 |
GO:0070167 | regulation of biomineral tissue development | 7.998664e-3 |
GO:0072162 | metanephric mesenchymal cell differentiation | 8.056729e-3 |
GO:0051029 | rRNA transport | 8.056729e-3 |
GO:0046898 | response to cycloheximide | 8.056729e-3 |
GO:0051224 | negative regulation of protein transport | 8.073386e-3 |
GO:0002634 | regulation of germinal center formation | 8.121379e-3 |
GO:0002011 | morphogenesis of an epithelial sheet | 8.148010e-3 |
GO:0051225 | spindle assembly | 8.177483e-3 |
GO:0045409 | negative regulation of interleukin-6 biosynthetic process | 8.254767e-3 |
GO:0010801 | negative regulation of peptidyl-threonine phosphorylation | 8.254767e-3 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 8.355797e-3 |
GO:0060426 | lung vasculature development | 8.362156e-3 |
GO:0045768 | positive regulation of anti-apoptosis | 8.408344e-3 |
GO:0055001 | muscle cell development | 8.424471e-3 |
GO:0007126 | meiosis | 8.447784e-3 |
GO:2000345 | regulation of hepatocyte proliferation | 8.545281e-3 |
GO:0031647 | regulation of protein stability | 8.621748e-3 |
GO:0006418 | tRNA aminoacylation for protein translation | 8.656005e-3 |
GO:0001988 | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 8.796925e-3 |
GO:0060112 | generation of ovulation cycle rhythm | 8.796925e-3 |
GO:0050864 | regulation of B cell activation | 8.805908e-3 |
GO:0002792 | negative regulation of peptide secretion | 8.872322e-3 |
GO:0071218 | cellular response to misfolded protein | 8.884227e-3 |
GO:0055069 | zinc ion homeostasis | 8.951210e-3 |
GO:0007129 | synapsis | 8.951210e-3 |
GO:0060931 | sinoatrial node cell development | 8.963242e-3 |
GO:0003167 | atrioventricular bundle cell differentiation | 8.963242e-3 |
GO:0034114 | regulation of heterotypic cell-cell adhesion | 8.998022e-3 |
GO:0070587 | regulation of cell-cell adhesion involved in gastrulation | 8.998022e-3 |
GO:0070661 | leukocyte proliferation | 9.001873e-3 |
GO:0045767 | regulation of anti-apoptosis | 9.020395e-3 |
GO:0006270 | DNA-dependent DNA replication initiation | 9.034883e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 9.034883e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 9.204764e-3 |
GO:0008228 | opsonization | 9.243745e-3 |
GO:0000226 | microtubule cytoskeleton organization | 9.740073e-3 |
GO:0043631 | RNA polyadenylation | 9.744810e-3 |
GO:0072239 | metanephric glomerulus vasculature development | 9.867628e-3 |
GO:0045217 | cell-cell junction maintenance | 9.867628e-3 |
GO:0046929 | negative regulation of neurotransmitter secretion | 9.899393e-3 |
GO:0043547 | positive regulation of GTPase activity | 9.910494e-3 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 9.957269e-3 |
GO:0035308 | negative regulation of protein dephosphorylation | 9.983849e-3 |
GO:0000012 | single strand break repair | 9.983849e-3 |
GO:0051583 | dopamine uptake | 1.008507e-2 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 1.022813e-2 |
GO:0043134 | regulation of hindgut contraction | 1.023602e-2 |
GO:0032602 | chemokine production | 1.023602e-2 |
GO:0003417 | growth plate cartilage development | 1.027402e-2 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 1.059918e-2 |
GO:0018205 | peptidyl-lysine modification | 1.061894e-2 |
GO:0072161 | mesenchymal cell differentiation involved in kidney development | 1.075494e-2 |
GO:0003323 | type B pancreatic cell development | 1.075494e-2 |
GO:0030223 | neutrophil differentiation | 1.075494e-2 |
GO:0034201 | response to oleic acid | 1.076702e-2 |
GO:0070192 | chromosome organization involved in meiosis | 1.093061e-2 |
GO:0016573 | histone acetylation | 1.093182e-2 |
GO:0007603 | phototransduction, visible light | 1.099082e-2 |
GO:0001955 | blood vessel maturation | 1.099082e-2 |
GO:0006917 | induction of apoptosis | 1.099842e-2 |
GO:0070925 | organelle assembly | 1.115124e-2 |
GO:0035909 | aorta morphogenesis | 1.128413e-2 |
GO:0090185 | negative regulation of kidney development | 1.139254e-2 |
GO:0021993 | initiation of neural tube closure | 1.139254e-2 |
GO:0042116 | macrophage activation | 1.147483e-2 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 1.149278e-2 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.159466e-2 |
GO:0071870 | cellular response to catecholamine stimulus | 1.159466e-2 |
GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway | 1.159466e-2 |
GO:0072133 | metanephric mesenchyme morphogenesis | 1.161648e-2 |
GO:0019543 | propionate catabolic process | 1.161648e-2 |
GO:0050908 | detection of light stimulus involved in visual perception | 1.169872e-2 |
GO:0034143 | regulation of toll-like receptor 4 signaling pathway | 1.179529e-2 |
GO:0003007 | heart morphogenesis | 1.187841e-2 |
GO:0051321 | meiotic cell cycle | 1.208943e-2 |
GO:0000819 | sister chromatid segregation | 1.230519e-2 |
GO:0046685 | response to arsenic-containing substance | 1.233931e-2 |
GO:0090103 | cochlea morphogenesis | 1.246743e-2 |
GO:0012502 | induction of programmed cell death | 1.261028e-2 |
GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.262598e-2 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 1.268026e-2 |
GO:0020028 | hemoglobin import | 1.281072e-2 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.281072e-2 |
GO:0034135 | regulation of toll-like receptor 2 signaling pathway | 1.292194e-2 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 1.292194e-2 |
GO:0060376 | positive regulation of mast cell differentiation | 1.292194e-2 |
GO:0002508 | central tolerance induction | 1.292194e-2 |
GO:0009589 | detection of UV | 1.292194e-2 |
GO:0002897 | positive regulation of central B cell tolerance induction | 1.292194e-2 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 1.303069e-2 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 1.315021e-2 |
GO:0021984 | adenohypophysis development | 1.315021e-2 |
GO:0001922 | B-1 B cell homeostasis | 1.315021e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.317250e-2 |
GO:0007141 | male meiosis I | 1.338899e-2 |
GO:0009235 | cobalamin metabolic process | 1.351353e-2 |
GO:0006925 | inflammatory cell apoptosis | 1.351353e-2 |
GO:0030857 | negative regulation of epithelial cell differentiation | 1.368396e-2 |
GO:0070979 | protein K11-linked ubiquitination | 1.372451e-2 |
GO:0010755 | regulation of plasminogen activation | 1.376325e-2 |
GO:0009081 | branched chain family amino acid metabolic process | 1.386409e-2 |
GO:0071310 | cellular response to organic substance | 1.420016e-2 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.427993e-2 |
GO:0003327 | type B pancreatic cell fate commitment | 1.427993e-2 |
GO:0010884 | positive regulation of lipid storage | 1.433207e-2 |
GO:0060312 | regulation of blood vessel remodeling | 1.434349e-2 |
GO:0002698 | negative regulation of immune effector process | 1.445544e-2 |
GO:0016032 | viral reproduction | 1.452002e-2 |
GO:0021592 | fourth ventricle development | 1.460923e-2 |
GO:0002376 | immune system process | 1.475589e-2 |
GO:0060445 | branching involved in salivary gland morphogenesis | 1.477365e-2 |
GO:0010159 | specification of organ position | 1.488770e-2 |
GO:2000352 | negative regulation of endothelial cell apoptosis | 1.539936e-2 |
GO:0046666 | retinal cell programmed cell death | 1.559639e-2 |
GO:0033345 | asparagine catabolic process via L-aspartate | 1.559639e-2 |
GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation | 1.559639e-2 |
GO:0006312 | mitotic recombination | 1.559639e-2 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 1.561313e-2 |
GO:0010470 | regulation of gastrulation | 1.574166e-2 |
GO:0019048 | virus-host interaction | 1.585573e-2 |
GO:0051248 | negative regulation of protein metabolic process | 1.594929e-2 |
GO:0071727 | cellular response to triacyl bacterial lipopeptide | 1.597145e-2 |
GO:0060971 | embryonic heart tube left/right pattern formation | 1.597145e-2 |
GO:0090045 | positive regulation of deacetylase activity | 1.597145e-2 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.597145e-2 |
GO:0042495 | detection of triacyl bacterial lipopeptide | 1.597145e-2 |
GO:0042938 | dipeptide transport | 1.597145e-2 |
GO:0060921 | sinoatrial node cell differentiation | 1.597961e-2 |
GO:0047496 | vesicle transport along microtubule | 1.597961e-2 |
GO:0048294 | negative regulation of isotype switching to IgE isotypes | 1.607599e-2 |
GO:0043966 | histone H3 acetylation | 1.614535e-2 |
GO:0060134 | prepulse inhibition | 1.620969e-2 |
GO:0032673 | regulation of interleukin-4 production | 1.629867e-2 |
GO:0046488 | phosphatidylinositol metabolic process | 1.635253e-2 |
GO:0042035 | regulation of cytokine biosynthetic process | 1.644874e-2 |
GO:0001569 | patterning of blood vessels | 1.648391e-2 |
GO:0034121 | regulation of toll-like receptor signaling pathway | 1.661719e-2 |
GO:0090276 | regulation of peptide hormone secretion | 1.709140e-2 |
GO:0050796 | regulation of insulin secretion | 1.711640e-2 |
GO:0032101 | regulation of response to external stimulus | 1.715760e-2 |
GO:0046651 | lymphocyte proliferation | 1.725711e-2 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.728644e-2 |
GO:0015937 | coenzyme A biosynthetic process | 1.732989e-2 |
GO:0072143 | mesangial cell development | 1.743622e-2 |
GO:0090273 | regulation of somatostatin secretion | 1.757233e-2 |
GO:0007262 | STAT protein import into nucleus | 1.757233e-2 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 1.757233e-2 |
GO:2000172 | regulation of branching morphogenesis of a nerve | 1.776728e-2 |
GO:0030967 | ER-nuclear sterol response pathway | 1.776728e-2 |
GO:0010624 | regulation of Schwann cell proliferation | 1.776728e-2 |
GO:0019541 | propionate metabolic process | 1.787027e-2 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.790294e-2 |
GO:0019852 | L-ascorbic acid metabolic process | 1.820388e-2 |
GO:0050777 | negative regulation of immune response | 1.837119e-2 |
GO:0043687 | post-translational protein modification | 1.874986e-2 |
GO:0046825 | regulation of protein export from nucleus | 1.893370e-2 |
GO:0060926 | pacemaker cell development | 1.898136e-2 |
GO:0060932 | His-Purkinje system cell differentiation | 1.898136e-2 |
GO:0006474 | N-terminal protein amino acid acetylation | 1.898136e-2 |